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ABSTRACT 
 
The study investigated knowledge, attitudes and vaccination status of registered nurses 
regarding prevention and control of hepatitis B (HB). An analytical, cross-sectional study 
was conducted, and data was collected using self-administered questionnaires. 53.0% 
of the respondents (n=219) had good knowledge and 96.3% had positive attitudes 
regarding HB prevention and control. 86.8% had received at least 1 dose of the HB 
vaccine, but only 54.7% had received the 3 doses for complete vaccination. A positive 
attitude score was a significant predictor of HB vaccination uptake (OR=1.424, 
p=0.003). Female registered nurses were 3.479 times (95% CI: 1.495-8.098; p=0.004) 
more likely to be vaccinated than male registered nurses. Registered nurses are aware 
that hepatitis B virus infection can be prevented by a safe and effective vaccine, 
however, there is need to improve awareness and encourage complete HB vaccination 
uptake among all registered nurses to ensure their protection against the risk of HBV 
infection. 
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LIST OF OPERATIONAL DEFINITIONS 
 
Acute hepatitis B: A new infection caused by HBV which may last up to 6months with or 
without symptoms. Clinical signs and symptoms include anorexia, malaise, nausea, vomiting, 
abdominal pains, and jaundice, and these appear within 4-12weeks.  
 
Antibody to hepatitis B surface antigen (anti-HBs): Presence of this antibody indicates 
recovery and immunity from HBV infection. Anti-HBs also develops in a person who has been 
successfully vaccinated against Hepatitis B.  
 
Antibody to hepatitis B core antigen (anti-HBc): There are two types of this antibody; IgG 
and IgM. Presence of IgG anti-HBc indicates past exposure or chronic infection and IgM anti-
HBc indicates recent or acute infection with HBV. 
 
Attitude: A way of behaving caused by one’s feeling or opinion about something or someone 
(Hawker & Waite 2007:53). The attitudes of registered nurses were based on their responses 
to 9 statements, and the responses were structured on a 3-point Likert scale. 
 
Chronic HBV infection: Presence of HBsAg for more than 6 months. 
 
Clinical area of practice: Workstation or department of the hospital where a registered nurse is 
working. 
 
Hepatitis B (HB): Inflammation of the liver caused by the hepatitis B virus (HBV). 
 
Hepatitis B e-antigen (HBeAg): An antigen found in the blood during acute and chronic 
infection indicating active replication of HBV.  
 
Hepatitis B surface antigen (HBsAg): A protein on the surface of the virus that can be 
detected in high levels in serum during acute or chronic HBV infection.  
 
Horizontal transmission: The spreading of HBV through close person to person contact. 
 
Knowledge: The general understanding or familiarity with a subject that you get by experience 
or study (Hawker & Waite 2007:509). Knowledge of the registered nurses was determined using 
11 questions with each correct answer scoring 1.  
 
viii 
 
 
Non-responder: A person who fails to produce adequate antibody levels after complete HB 
vaccination. 
 
Perinatal (vertical) transmission: This refers to transmission of HBV from an infected mother 
and her baby, immediately before and after birth.  
 
Registered nurse: A person medically trained to take care of the sick, and registered with the 
Nursing and Midwifery Council of Botswana. 
 
Responder: A person who produces protective antibody levels after complete HB vaccination. 
 
Standard precautions: These are guidelines meant to reduce the risk of transmission of 
pathogens by providing a high level of protection to patients, HCWs, and visitors. 
 
Vaccination status: The condition of the registered nurses with regard to vaccination against 
hepatitis B virus. Vaccination refers to the injection of a killed or attenuated microbe in order to 
stimulate the immune system thereby preventing disease or infection (WHO 2017). 
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CHAPTER 1 
 
ORIENTATION TO THE STUDY 
 
1.1 BACKGROUND TO THE STUDY 
 
The most serious occupational health hazard faced by health care workers (HCWs) is 
exposure to blood-borne pathogens. Three pathogens that account for most cases due 
to their prevalence in patients and the severity of the disease they cause are hepatitis B 
virus (HBV), hepatitis C virus (HCV) and Human Immunodeficiency virus (HIV). The 
highest proportion of occupational transmission is due to percutaneous injuries (Deuffic-
Burban, Delarocque-Astagneau, Abiteboul, Bouvet & Yazdanpanah 2011:4). HBV is a 
highly infectious blood borne pathogen that causes acute and chronic hepatitis B. In 
health facilities, health care workers are at risk for exposure to HBV from infected 
patients and, if infected, are similarly at risk of transmitting HBV to patients.  
 
Botswana has the world’s second highest HIV prevalence (24.8%) of adults aged 15-49 
years old and the majority of the country’s infectious disease burden is HIV-related 
(Chandra, Mullan, Ho-Foster, Langeveldt, Caruso, Motsumi & Kestler 2014:110). A 
study conducted in Gaborone, Botswana revealed that HBV co-infection is relatively 
common in HIV infected adults. (Patel, Davis, Tolle, Mabikwa & Anabwani 2011:390). 
Another study conducted in Gaborone revealed a higher prevalence of chronic HBV 
infection of 3.1% among HIV-infected pregnant women compared with 1.1% among 
HIV-uninfected women (Mbangiwa, Kasvosve, Anderson, Thami, Choga, Needleman, 
Phinius, Moyo, Leteane, Leidner, Blackard, Mayondi, Kammerer, Musonda, Essex, 
Lockman & Gaseitsiwe 2018). HIV positive patients admitted in Nyangabgwe Hospital 
are likely to comprise in a significant number of HBV carriers, resulting in a high risk of 
exposure to HBV for HCWs and other patients. 
 
1.2  PROBLEM STATEMENT 
 
Nurses frequently get in contact with patients’ blood and potentially infectious body 
fluids while performing their duties, as a result, they are at an increased risk of exposure 
to HBV. The level of risk depends on the number of patients with HBV infection, the 
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standard precautions taken while nursing the patients and the HB vaccination status. 
Regarding hepatitis B (HB) vaccination, previous studies have found sub-optimal 
protection among HCWs.  
 
In Botswana government health facilities, the decision for HB vaccination uptake is 
dependent upon the health care worker’s knowledge and attitude regarding HBV 
prevention and control.  Despite the availability of a free, safe and effective vaccine for 
HCWs, there is a possibility that a significant number of registered nurses at 
Nyangabgwe Hospital are still not protected against HBV, hence putting other HCWs 
and patients at risk.  
 
1.3 PURPOSE OF THE STUDY 
 
This study aims to investigate the knowledge, attitudes and vaccination status of 
registered nurses in Botswana regarding hepatitis B prevention and control. 
 
1.3.1 Research questions 
 
 What is the knowledge of registered nurses at Nyangabgwe Hospital regarding 
HBV prevention and control? 
 What is the attitude of registered nurses at Nyangabgwe Hospital regarding HBV 
prevention and control? 
 What is the vaccination status of registered nurses at Nyangabgwe Hospital 
regarding HBV prevention and control? 
 Is there any association between (1) knowledge and vaccination status, (2) 
attitudes and vaccination status, and (3) clinical area of practice and vaccination 
status, among registered nurses at Nyangabgwe Hospital regarding HBV 
prevention and control? 
 What are the predictors of HBV vaccination uptake among the registered nurses 
at Nyangabgwe Hospital? 
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1.3.2 Research objectives 
 
 To assess the knowledge of registered nurses at Nyangabgwe Hospital 
regarding HBV prevention and control. 
 To assess the attitude of registered nurses at Nyangabgwe Hospital regarding 
HBV prevention and control. 
 To explore the vaccination status of registered nurses at Nyangabgwe Hospital 
regarding HBV prevention and control. 
 To determine if there are any associations between knowledge and vaccination 
status, attitudes and vaccination status, and clinical area of practice and 
vaccination status, among registered nurses at Nyangabgwe Hospital regarding 
hepatitis B prevention and control. 
 To determine the predictors of HBV vaccination uptake among the registered 
nurses at Nyangabgwe Hospital.  
 
1.4 JUSTIFICATION OF THE STUDY 
 
Nurses contribute the largest proportion of HCWs and their general knowledge and 
attitudes regarding the prevention of communicable diseases have a direct impact on 
the goals of public health. Occupational exposures are common within health facilities, 
putting both nurses and patients at risk of infections. The study findings may identify 
gaps in issues related to occupational health and safety regulations. It is therefore 
important to evaluate the level of awareness of registered nurses in the fight against 
HBV so that effective programmes through policies that ensure protection for all HCWs 
and their patients can be developed and implemented.  
 
1.5 SUMMARY 
 
This chapter has provided the background to the study and the purpose of the study. 
The next chapter will present a literature review on the epidemiology of HBV, prevention 
and control of HBV infection, as well as knowledge, attitudes and vaccination status of 
nurses and other HCWs regarding the HB prevention and control. 
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CHAPTER 2 
 
LITERATURE REVIEW 
 
2.1 INTRODUCTION 
 
The previous chapter outlined the purpose of the study, the research objectives and the 
problem statement. This chapter presents a review of the literature on the epidemiology 
of HBV, prevention and control of HBV infection, as well as knowledge, attitudes and 
vaccination status of nurses regarding the HB prevention and control. 
 
2.2 AETIOLOGY OF HEPATITIS 
 
Hepatitis is an inflammation of the liver (WHO 2015). The condition can be self-limiting 
or can progress to fibrosis (scarring), cirrhosis or liver cancer. Hepatitis viruses are the 
most common causes of hepatitis in the world but other infections, toxic substances and 
auto-immune diseases can also cause hepatitis. There are five main hepatitis viruses, 
referred to as types A, B, C, D and E (WHO 2015). Hepatitis B is a major health 
problem in most parts of the world including sub-Saharan Africa (WHO 2017). 
 
2.3 HBV STRUCTURE 
 
HBV is a double-stranded deoxyribonucleic acid (DNA) virus, a species of the genus 
Orthohepadnavirus, and a member of the Hepadnaviridae family of viruses. The virus 
particle, called Dane particle (virion), is made up of an outer lipid envelope and an 
icosahedral nucleocapsid core composed of protein. The nucleocapsid encloses the 
viral DNA and a DNA polymerase that has reverse transcriptase activity similar to 
retroviruses. The nucleocapsid core contains hepatitis B core antigen (HBcAg). The 
outer lipid envelope contains hepatitis B surface antigens (HBsAg). Hepatitis B 
endogenous antigen (HBeAg) is a soluble antigen that can be released from the 
nucleocapsid core particles (Liang 2009:S14). 
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2.4 DIAGNOSIS  
 
The general diagnosis of hepatitis is based on clinical, biochemical, histological and 
serological findings (Liang 2009:S15). However, specific diagnosis of HBV infection is 
based on serologic findings focusing on the detection of several HBV specific antigens 
and antibodies in the blood. Different serologic markers or combination of markers are 
used to identify different phases of HBV infection and to determine whether a patient 
has acute or chronic HBV infection, is immune to HBV as a result of prior infection or 
vaccination, or is susceptible to infection (CDC 2005). HBV DNA followed shortly 
afterward by HBsAg and HBeAg are the first viral markers detected in serum (Liang 
2009:S15). 
 
2.4.1 Serological markers 
 
 Hepatitis B surface antigen (HBsAg): A protein on the surface of the virus. It 
can be detected in high levels in serum during acute or chronic HBV infection. 
The presence of HBsAg indicates that the person is infectious. This is the first 
detectable marker of infection and is present as early as the incubation period. 
HBsAg is the antigen used to make hepatitis B vaccine (CDC 2005). 
 Hepatitis B surface antibody (anti-HBs): The body normally produces 
antibodies to HBsAg as part of the normal immune response to infection. The 
presence of this antibody indicates recovery and immunity from HBV infection. 
Anti-HBs also develops in a person who has been successfully vaccinated 
against hepatitis B (CDC 2005). 
 Total hepatitis B core antibody (anti-HBc): Appears at the onset of symptoms 
in acute hepatitis B and persists for life. The presence of anti-HBc indicates 
previous or ongoing infection with hepatitis in an undefined time frame (CDC 
2005). 
 IgM antibody to hepatitis B core antigen (IgM anti-HBc): The presence of this 
antibody indicates a recent, acute infection with HBV (CDC 2005) 
 IgG antibody to hepatitis B core antigen (IgG anti-HBc): The most sensitive 
marker of past exposure to HBV, its presence indicates chronic infection (CDC 
2005). 
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 Hepatitis B e-antigen (HBeAg): An antigen found in the blood during acute and 
chronic HBV infection. A positive HBeAg test indicates that the HBV is actively 
replicating and the infected person has high levels of the virus (CDC 2005). 
 Antibody to hepatitis B e-antigen (anti-HBe): This antibody is produced 
temporarily during acute HBV infection or consistently during or after a burst in 
viral replication. A person who converts from positive HBeAg to anti-HBe is more 
likely to achieve long-term clearance of the virus. Presence of anti-HBe indicates 
loss of HBV replication and initiation of recovery (CDC 2005). 
 
Table 2.1 Interpretation of hepatitis B serologic test results 
 
Serological marker Status Clinical interpretation 
HBsAg 
anti-HBc 
anti HBs 
Negative 
Negative 
Negative 
Susceptible 
HBsAg 
anti-HBc 
anti-HBs 
Negative 
Positive 
Positive 
Immune due to natural infection 
HBsAg 
anti-HBc 
anti-HBs 
Negative 
Negative 
Positive 
Immune due to hepatitis B vaccination 
HBsAg 
anti-HBc 
IgM anti-HBc 
anti-HBs 
Positive 
Positive 
Positive 
Negative 
Acute infection 
HBsAg 
anti-HBc 
IgM anti-HBc 
anti-HBs 
Positive 
Positive 
Negative 
Negative 
Chronic infection 
HBsAg 
anti-HBc 
anti-HBs 
negative 
positive 
negative 
Interpretation unclear; four possibilities 
 
1 Resolved infection (most common) 
2 False-positive anti-HBc, thus 
susceptible 
3 “Low level” chronic infection 
4 Resolving acute infection 
(CDC 2005) 
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2.5 TRANSMISSION OF HBV 
 
HBV can survive outside the body for at least 7 days. During this time, the virus can still 
cause infection to a person who is not protected against the virus. The incubation period 
of HBV varies from 30 to 180 days with an average of 75 days. HBV is spread by 
percutaneous or mucosal exposure to infected blood and various body fluids such as 
saliva, menstrual, vaginal and seminal fluids. It can also be sexually transmitted. 
Infection can occur during medical, surgical and dental procedures through the use of 
objects contaminated with infected blood and body fluids (WHO 2017). 
 
Transmission can be classified as vertical or perinatal if it is spread from an infected 
mother to the child at birth, horizontal if it is through close person to person contact, 
parenteral when it is through injections or other invasive medical procedures or injuries, 
and sexual when it is through sexual contact (Mathews, Robotin & Allard 2014:44). In 
highly endemic areas, HBV is most commonly spread from mother to child at birth 
(perinatal transmission) or through horizontal transmission (exposure to infected blood 
and other body fluids), especially from an infected child to an uninfected child during the 
first 5 years of life (WHO 2017). Infected children may spread the virus to other children 
if there is frequent contact (for example, playground contact) thereby making direct 
contact with infected body fluids inevitable. High levels of HBV DNA were found in the 
saliva of HBeAg (+) children, suggesting saliva as a vehicle for horizontal transmission 
of HBV among children (Heiberg, Hoegh, Ladelund, Niesters & Hogh 2010:465). One 
study concluded that tears from children with chronic hepatitis B virus infection are 
infectious vehicles of HBV transmission (Komatsu, Inui, Sogo, Tateno, Shimokawa & 
Fujisawa 2012:478).  
 
In a hospital setting, HBV can be transmitted from one patient to the other, from one 
patient to the HCW and from the HCW to the patient. The three main routes of 
transmission are needle-stick injuries (NSIs) resulting in the direct transmission of 
infected blood or body fluids, direct contact of non-intact skin or mucous membrane with 
infected blood or body fluids, and indirect contact of contaminated surface with non-
intact skin or mucous membrane. The analysis of transmission pathways showed that 
some breaches in infection control measures, such as administration of drugs using 
multi-vial compounds and capillary blood sampling, are the most frequent routes for 
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patient-to-patient transmission of hepatitis B virus (Lanini, Puro, Lauria, Fusco, Nisi & 
Ippolito 2009). There are still countries where blood transfusions, organ transplants and 
other medical interventions pose an extreme risk because donors are not screened for 
HBV. In most countries where screening is in place, the risk of infection is low. 
Consequently, WHO strongly recommends that all blood donations be tested for HBV to 
ensure blood safety and avoid accidental transmission to recipients of blood and blood 
products (WHO 2017). 
 
Exposure through injuries from contaminated needles is the most common mode of 
patient to HCW transmission. In the United States, from 1997 to 1998, more than 
385,000 NSIs occurred annually (MacCannell, Laramie, Gomaa & Perz 2010:24). In the 
United Kingdom, 37% of nurses had sustained a NSI injury at some stage during their 
career (Muljono, Wijayadi & Sjahril 2018:90). Approximately 40–60% of the 
occupational HBV infections arise due to sharps injuries in developing countries. A NSI 
on average inoculates roughly the quantity of blood that could probably carry up to 100 
infectious doses of HBV. The transmission of HBV is dependent on the degree of 
contact with infectious material as well as the HBeAg status of the source. The risk of 
transmission of HBV is high (32%–67%) when blood is positive for both HBsAg and 
HBeAg. However, the risk of transmission is less than 6% when HBeAg is negative 
(Kashyap, Tiwari & Prakash 2018:33). 
 
In as much as HCWs are at risk for exposure to HBV from infected patients, if infected, 
they are at risk of transmitting HBV to patients. Published cases of HBV transmission 
from HCW to patient are relatively rare, having decreased in frequency following the 
introduction of standard (universal) precautions, adoption of enhanced percutaneous 
injury precautions such as double-gloving in surgery, and routine HBV vaccination of 
HCWs (Lewis, Enfield & Sifri 2015:488). To be at risk of transmitting HBV infection to a 
patient, the HCW requires to be viremic and there has to be a direct contact of blood or 
body fluid between the two. Hence the high level of viremia, the clinical setting of an 
exposure-prone procedure or the degree of contact with blood and body fluid are the 
only factors that would determine this kind of transmission (Kashyap et al 2018:32). 
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2.6 EPIDEMIOLOGY 
 
2.6.1 Global perspective 
 
In 2015, an estimated 257 million people were living with chronic HBV infection globally. 
The epidemic caused by HBV affects mostly the WHO African Region and the Western 
Pacific Region (WHO 2017). 
 
Hepatitis B prevalence is highest in the WHO Western Pacific Region and the WHO 
African Region where 6.1 % and 6.2 % of the adult population is infected. In 2015 the 
global prevalence of HBV infection in the general population was 3.5%. Among those 
born before the introduction of hepatitis B vaccine, the proportion of persons living with 
chronic HBV remains high (WHO 2017). About 2.7 million of the 36.7 million living with 
HIV worldwide are also infected with HBV. The global prevalence of HBV infection in 
HIV-infected persons is 7.4% (WHO 2017). 
 
2.6.2 Epidemiology in Botswana and other African countries 
 
The prevalence of HBV infection is similar across different groups of HIV-infected 
persons (WHO 2017). Most HIV/HBV co-infected persons live in sub-Saharan Africa. 
 
In Southern Africa, a study conducted among South African and Zambian patients in 
2008 reported an HIV/HBV co-infection rate of 7.4%; another study conducted amongst 
South African and Botswana patients in 2013 reported almost the same HIV/HBV co-
infection rate of 7.0%. (Mandiwana & Tshitenge 2017:95). Available data suggests that 
approximately 8% of the general population across Southern Africa have been infected 
with HBV. Chronic HBV infection is a common condition in Zambia. From an HIV cohort, 
the prevalence of chronic HBV is 10-12% (WHO 2017). 
 
The prevalence of HBsAg among nurses in South Africa was 1.8%, and all were black 
nurses. HBV is endemic in South Africa (Mosendane, Kew, Osih & Mahomed 
2012:153). A study conducted in Nigeria found that 2.5% of midwives contracted HBV 
infection through practice may be due to a breach in universal precautions or 
unvaccinated status. In the same study, it was revealed that 30.8% did not practice 
universal precautions and 36.7% had not received hepatitis B vaccination (Ella, 
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Samson-Akpan & Akpabio 2016:97-98). According to Tanzania National Blood 
Transfusion Services (TNBTS) report, HBV infection was the most frequent Transfusion 
Transmissible Infection (TTI) detected in all blood units collected in the country with a 
detection rate of 6.2% and contributing 42% of all TTIs (Kilonzo, Gunda, Mpondo, 
Bakshi & Jaka 2018). Another study in Tanzania revealed an overall prevalence of 
chronic HBV infection among HCWs of 7.0 % (Mueller, Stoetter, Kalluvya, Stich, 
Majinge, Weissbrich & Kasang 2015). In Cameroon, seroprevalence of HBsAg has 
been reported to be 10.1 % in a general population of blood donors, 10.2 % among 
pregnant women and 23.7 % among HIV-infected patients (Tatsilong, Noubiap, 
Nansseu, Aminde, Bigna, Ndze & Moyou 2016). 
 
Two similar studies conducted in Botswana on HIV/HBV co-infection revealed HBsAg-
positive rates of 5.3% (Patel et al 2011:391) and 5.1% (Mandiwana & Tshitenge 
2017:95). A study conducted among HIV-positive women in South Africa and Botswana 
reported an HBsAg prevalence of 7.0% in the combined cohort and 3.8% in the 
Botswana cohort (Matthews, Beloukas, Malik, Carlson, Jooste, Ogwu, Shapiro, Riddell, 
Chen, Luzzi, Jaggernath, Jesuthasan, Ndung’u, Goulder, Geretti & Klenerman 2015).  
 
2.7 SIGNS AND SYMPTOMS 
 
The symptoms of hepatitis B depend on whether a person has acute or chronic 
hepatitis B infection.  
 
2.7.1 Acute hepatitis 
 
Acute hepatitis develops after the incubation period and is characterised by elevated 
alanine transaminase (ALT) levels lasting 4–12 weeks (Mathews et al 2008:45). Most 
people do not experience any symptoms during the acute infection phase. However, 
some people have an acute illness with symptoms that last several weeks, including 
yellowing of the skin and eyes (jaundice), dark urine and pale-coloured stools, extreme 
fatigue, nausea, vomiting and right upper quadrant abdominal pain. A small subset of 
persons with acute hepatitis can develop acute liver failure, which can lead to death 
(WHO 2017).  
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2.7.2 Chronic hepatitis 
 
The transition from acute to chronic infection shows a failure of the immune response to 
eliminate the virus. Chronic hepatitis B (CHB) is defined serologically as HBsAg 
positivity for more than 6 months. Progression from acute to CHB infection is influenced 
by the age at which the subject acquires the virus (Mathews et al 2008:46). 80-90% of 
infants infected during the first year of life develop chronic infections and 30-50% of 
children infected before the age of 6 years develop chronic infections (WHO 2017). This 
is related to the inability of the immune system to recognise the virus and the high level 
of viral replication results in immunological tolerance. In adults, a cell-mediated 
response to foreign HBV proteins results in acute hepatitis, which may be 
asymptomatic, and the response leads to clearance of the infection in all but 1–5% of 
patients (Mathews et al 2008:46). In some people, the hepatitis B virus can cause a 
chronic liver infection that can later develop into cirrhosis (a scarring of the liver) or liver 
cancer (WHO 2017).  
 
2.8 PREVENTION AND CONTROL IN HEALTH-CARE FACILITIES 
 
2.8.1 Hepatitis B vaccination 
 
The hepatitis B vaccine is the mainstay of hepatitis B prevention. The complete vaccine 
series induces protective antibody levels in more than 95% of infants, children and 
young adults. Protection lasts at least 20 years and is probably lifelong (WHO 2017).  
 
WHO recommends that all infants receive the hepatitis B vaccine as soon as possible 
after birth, preferably within 24 hours. In 2015, the prevalence of HBV infection in 
children under 5 years of age was about 1.3% compared with about 4.7% in the pre-
vaccination era. People in the high-risk groups should also be vaccinated if not 
previously vaccinated. These high-risk groups include people who frequently require 
blood and blood products, dialysis patients, recipients of solid organ transplantations, 
injectable drug users, household and sexual contact of people with chronic HBV 
infection, HCWs and others who may be exposed to blood and other body fluids through 
their work; and travellers to endemic areas who have not completed their HB 
vaccination series (WHO 2017).  
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Given that HBV is a condition that is preventable by vaccination, all individuals should 
ideally be vaccinated as a precaution before entering the health care workforce. Once 
vaccinated, it is recommended that HCWs are tested for anti-HBs, to check if they have 
responded to the vaccine. Testing for anti-HBs should be done 1 to 2 months after 
completion of the three-dose series. Despite the high efficacy of the HBV vaccine, 
nearly 5% of immunocompetent individuals fail to respond to the primary HBV series. 
(Walayat, Ahmed, Martin, Puli, Cashman & Dhillon 2015:2505). 
 
Although HBV infection rates among HCWs were higher than those of the general 
population before the development of the HBV vaccine, this situation has been reversed 
with many HCWs having previously received the vaccine. Since the introduction of HBV 
vaccine in 1982, a study in the United States showed an increasing number of HCWs 
being fully vaccinated and a dramatic decrease in the number of HBV infections among 
HCWs who are now at lower risk of HBV infection than the general US population (CDC 
2005). 
 
2.8.2 Injection safety 
 
Injections are one of the widely used procedures in health care. The vast majority, 
approximately 90% of injections are given in curative care, 5% in immunisations and the 
remaining covering other indications, including transfusion of blood and blood products, 
intravenous administration of drugs and fluids and the administration of injectable 
contraceptives (WHO 2016). A safe injection is one that does not injure the recipient, 
does not expose the HCW to any preventable risk, and does not result in any waste that 
is likely to cause great harm to the community (Chaudhuri & Ray 2016:21). Eliminating 
unnecessary and unsafe injections can be effective strategies to protect against HBV 
transmission (WHO 2016).   
 
2.8.3 Screening of blood and blood products 
 
Blood transfusion is a life-saving intervention that has an essential role in patient 
management within health delivery systems. Blood safety strategies including a quality-
assured screening of all donated blood and blood components used for transfusion can 
prevent transmission of HBV. Worldwide in 2013, 97% of blood donations were 
screened and quality-assured, but gaps persist (WHO 2017). It is these gaps that can 
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result in transfusion-associated HBV (TAHBV) infections. There is a high incidence of 
TAHBV reported in patients receiving multiple transfusions in India (Sakwe & Sakwe 
2010:248). Among Zambian blood donors, up to 8% are chronically infected with HBV. 
The South African black population has the highest incidence of infection, with 
prevalences of antibody to the hepatitis B surface antigen (anti-HBs) of 42.9%, 3.4%, 
and 1.2% in black, Asian, and Caucasian blood donors, respectively (Mosendane et al 
2012:153). 
 
In Botswana, at the Francistown Regional Blood Transfusion, HBV screening is done 
using HBsAg as the only marker for active infection. In the vast majority of cases of HB, 
the detection of anti-HBc is of limited value as HBsAg is already present. In some 
cases, however, during the resolution of the infection, HBsAg may decline to below 
detectable levels (WHO 2009). It has been demonstrated that some HBsAg-negative 
and anti-HBc positive individuals continue to replicate HBV. Therefore the negative 
HBsAg in the blood of apparently healthy donor may not be sufficient to ensure the 
absence of circulating HBV, thus rendering the blood infectious. If anti-HBc screening is 
introduced for routine use, it would be necessary to distinguish between individuals who 
are anti-HBc reactive because of previous, resolved, natural HBV infection, and are thus 
non-infectious, from those who have unresolved HBV infection and are thus potentially 
infectious. While screening for anti-HBc is not recommended as a routine, countries, 
however, should determine the need for anti-HBc screening based on the prevalence 
and incidence of HBV infection (WHO 2009). 
  
The presence of anti-HBs is protective, therefore, anti-HBs testing of all anti-HBc 
reactive donations would be required to distinguish between infectious and non-
infectious individuals. In general, a level of anti-HBs at 100 mIU/mL is usually accepted 
as the minimum protective level in the context of blood screening; donations that are 
HBsAg negative, anti-HBc reactive with anti-HBs levels of 100mIU/mL or more are 
generally considered to be safe and acceptable for release for clinical or manufacturing 
use (WHO 2009). Highly sensitive and specific screening tests should be used. 
 
2.8.4 Post-exposure prophylaxis 
 
In a health-care facility, occupational exposures to HBV may occur. After exposure to 
HBV, appropriate and timely prophylaxis can prevent HBV infection. Post-exposure 
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prophylaxis (PEP) is based mainly on active immunisation with HB vaccine and passive 
immunisation with HBIG. The primary advantage of passive immunisation with 
preformed antibodies is the prompt availability of large amounts of antibody (Brooks, 
Carrol, Butel, Morse & Mietzner 2013:137). The mainstay of PEP is the hepatitis B 
vaccine, but, in certain circumstances, HBIG (hepatitis B immunoglobulin) is 
recommended in addition to the vaccine for added protection. Hepatitis B vaccine is 
highly effective in preventing acute infection after exposure if given within 7 days and 
preferably within 48 hours. Post-exposure management is determined by the 
vaccination status of the HCW and the HBV status of the source. An accelerated HB 
vaccine course may be required and this consists of doses at 0, 1 and 2 months (HPSC 
2016). 
 
HBIG is only indicated where the source is known HBsAg positive and where the 
recipient is a known non-responder to HBV vaccination. HBIG should ideally be given 
within 48 hours but not later than 7 days after exposure. Simultaneous administration of 
HBIG and HB vaccine dose is done on separate injection sites (HPSC 2016). 
 
2.8.4.1 Exposure to HBsAg positive source 
 
Unvaccinated HCWs should be given HBIG and initiated on accelerated HB vaccine 
course. Documented non-responders to a complete hepatitis B vaccine series should 
receive both HBIG and hepatitis B vaccine dose simultaneously. Fully vaccinated HCWs 
but anti-HBs unknown and those not fully vaccinated (<3 doses) should receive HBV 
vaccine dose, and HBIG if anti-HBs is <10mIU/ml (HPSC 2016). 
 
2.8.4.2 Exposure to unknown HBsAg source 
 
HCWs who are unvaccinated should be initiated on accelerated HB vaccine course. 
Fully vaccinated HCWs but anti-HBs unknown, those not fully vaccinated and non-
responders to HB vaccine series should receive HB vaccine dose. In non-responders, 
HBIG may be considered. In addition, every effort should be made to test the source. In 
both exposures, HCWs who are known responders to HBV vaccine (anti-HBs 
≥10mIU/ml) are protected and need no further vaccine doses, and for non-responders, 
an alternative vaccination strategy may be required (HPSC 2016). 
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2.8.5 Standard precautions  
 
These are standard guidelines meant to reduce the risk of transmission of blood-borne 
and other pathogens from both recognised and unrecognised sources. “Standard 
precautions” require that health care workers assume that the blood and body 
substances of all patients are potential sources of infection, regardless of the diagnosis, 
or presumed infectious status. Additional precautions are needed for diseases 
transmitted by air, droplets and contact. These are termed “additional (transmission-
based) precautions” (WHO 2004). Standard precautions provide a high level of 
protection to patients, health care workers and visitors. These include:· hand washing 
and antisepsis (hand hygiene), use of personal protective equipment when handling 
blood, body substances, excretions and secretions; appropriate handling of patient care 
equipment and soiled linen; prevention of needle-stick/sharp injuries; environmental 
cleaning and spills-management; and appropriate handling of waste (WHO 2004). 
 
2.9 KNOWLEDGE 
 
2.9.1 Knowledge regarding occupational risk 
 
HCWs are aware of their risk of occupational exposure to HBV infection. 96.8% of 
HCWs correctly identified their work as increasing the risk of acquiring HBV infection. In 
Bangladesh, 84.3% of nurses were aware that health workers are at risk of getting 
hepatitis B (Mehriban, Ahsan & Islam 2014:50). However, several studies have 
demonstrated that among HCWs, the knowledge relating to the occupational risk of 
contracting and transmission of HBV is low. A study conducted in Ghana revealed that 
although 94.4% of the nurses considered themselves susceptible to occupational 
infection of HBV, 7.4% of nurses did not know that splash of blood into mucous 
membranes/non intact skin poses a risk to the hepatitis infection, and only 9.3% knew 
that hepatitis B vaccine is used as post-exposure prophylaxis (Konlan, Aarah-Bapuah & 
Kombat 2017:258). In a study conducted in South Africa on occupational exposure to 
blood borne viruses, only 10.9% of the source patients were tested for HBV after 
exposure, on the other hand, as many as 68.9% were tested for HIV after exposure (De 
Villiers, Nel & Prinsloo 2007:14). A similar finding was observed amongst Nigerian 
dental auxiliaries where 74.7% of them agreed that it was easier to contract HIV than 
hepatitis B through needle-stick in the dental clinic (Azondo, Ehigiator & Ojo 2010:365). 
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This shows that HCWs are more alert towards HIV than HBV, despite HBV being more 
infectious. 
 
2.9.2 Knowledge about hepatitis B vaccine 
 
Awareness of the existence of HB vaccine has been found to be high among HCWs. 
95% of nurses in India (Amanpreet, Ramandeep, Simarpreet & Jyotsna 2016:258), 
93.4% of HCWs in Nigeria (Adekanle, Ndububa, Olowookere, Ijarotimi & Ijadunola 
2015) and 85% of HCWs in Zambia (Mungandi, Makasa & Musonda 2017). Regarding 
the level of awareness of hepatitis B vaccine, as little as 5.2% of HCWs in Nigeria had 
good knowledge and 11.9% did not know the number of doses required for complete 
protection (Samuel, Aderibigbe, Salami & Babatunde 2009:421). 48.2% of nurses in 
Ethiopia had good knowledge while the rest had unfavourable knowledge (Abeje & 
Azage 2015). 
 
2.10 ATTITUDES 
 
2.10.1 Attitudes regarding occupational risk 
 
Studies have revealed both negative and positive attitudes among HCWs regarding 
HBV as an occupational hazard. In a study conducted in northern Nigeria, 86.5% of 
primary HCWs had good knowledge of HB infection, however, their general perception 
of the occupational risk was low. 57.6% of them considered the risk as low while 25.7% 
said they stood no risk at all of contracting HBV from their work and 3.8% were unsure. 
(Daboer, Chingle & Banwat 2010:12). In a similar study in Southern Nigeria, 81% of 
HCWs had high knowledge, but two-fifths of them were of the opinion that they are not 
at risk of contracting the infection (Samuel et al 2009:421-422). 
 
2.10.2 Attitudes towards HB vaccination 
 
Hepatitis B vaccine has been widely accepted as an effective method in preventing HBV 
infection. A study in Tanzania showed that 96.8% of the HCWs agreed that the vaccine 
should be made compulsory and 89.7% had trust in the vaccine (Aaron, Nagu, 
Rwegasha & Komba 2017). A study conducted in Lusaka Zambia indicated that 97.0% 
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of the HCWs were willing to get vaccinated if the vaccine were to become available in 
their institution (Mungandi et al 2017). 
 
However, several studies have indicated negative attitudes towards the HBV 
vaccination amongst HCWs. Some of the reasons cited by HCWs for poor compliance 
to hepatitis B vaccination include busy schedules, time lost (and perhaps income) while 
getting the vaccination, procrastination, lack of knowledge about vaccine efficacy, 
perception of low-risk status and the bother of a sore arm (Samuel et al 2009:422). 
Iranian dentists mentioned unwillingness and fear of complications as reasons for non-
vaccination (Jalaleddin, Zahra, Kimia, Hesameddin & Zahra 2014:201). 
 
Unvaccinated HCWs in Tanzania mentioned they were very careful and observed 
standard precautions while at work (Aaron et al 2017). In a study in Ethiopia, the nurses 
mentioned the fear of side effects of the vaccine and being a new employee as some of 
the reasons for not being vaccinated (Yimer, Mohammed, Muhammed & Tsige 2017). 
 
2.11 VACCINATION COVERAGE 
 
Despite the availability of a safe and effective vaccine since 1982, overall coverage of 
hepatitis B vaccination among HCWs still remains unsatisfactory in many countries 
worldwide. A study conducted in Botswana among HCWs showed a vaccination 
coverage among nurses of 29.1% despite the availability of a free vaccine at their 
institution (Machiya, Burnett, Fernandes, Francois, De Schryver, Van Sprundel & 
Mphahlele 2015:258). One study in South Africa found high rates of active HBV 
infection and sub-optimal protection against HBV in HCWs suggesting the need to 
strengthen vaccination programmes through policies that ensures protection for all 
HCWs and their patients (Sondlane, Mawela, Razwiedani, Selabe, Lebelo, Rakgole, 
Mphahlele, Dochez, De Schryver & Burnett 2016:3835). 
 
A study conducted in Tanzania to determine hepatitis B vaccination coverage among 
334 HCWs found that 56.9% (190/334) of HCWs had received at least one dose of 
hepatitis B vaccination, while only 33.6% (117/334) were fully vaccinated (Aaron et al 
2017). In a similar study conducted among Iranian dentists, 48.1% were fully 
vaccinated, 3.1% had incomplete vaccination and 48.8% had no vaccination at all 
(Jalaleddin et al 2014:201). A follow-up study at one academic hospital in Johannesburg 
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South Africa, a decade later, indicated that 52.4% of the nurses were now protected 
against HBV infection from the previous 30.6% (Mosendane et al 2012:155).  A similar 
follow-up study in a Nigerian tertiary hospital showed a current vaccination coverage 
among HCWs of 65% from a previous 54%. Another study in Nigeria indicated that 
63.3% of midwives were fully vaccinated (Ella et al 2016:98). 
 
A study in Zambia conducted among 331 HCWs showed a very low vaccination 
coverage of 19.3% against hepatitis B (Mungandi et al 2017). Extremely low vaccination 
coverages were found in two studies in Ethiopia where only 8.8% of nurses (Yimer et al 
2017) and 5.4% of HCWs (Abeje & Azage 2015) were fully vaccinated. A study 
conducted in Bangladesh found that 59% of nurses were fully vaccinated. 
 
Among nurses, high vaccination rates of 92.4% were found in India (Amanpreet et al 
2016:258) and 81% in the United States (Simard, Miller, George, Wasley, Alter, Bell & 
Finelli 2007:783). A study conducted in Serbia found a fairly high vaccination rate of 
66.2% among HCWs (Kisic-Tepavcevic, Kanazir, Gazibara, Maric, Makismovic, 
Loncarevic & Pekmezovic 2017). 
 
2.12 SUMMARY 
 
HBV infection still remains an important health concern given that it is frequently 
unrecognised by clinicians. Occupational exposure to HBV is an everyday reality for 
HCWs but they seem to be more vigilant to HIV than HBV. HCWs are aware of the 
existence of the hepatitis B vaccine but their knowledge about the vaccine is generally 
low. Lack of knowledge has probably resulted in poor compliance to HB vaccination. 
Positive attitudes towards HB vaccination amongst HCWs have been noted. However, 
vaccination coverage still remains alarmingly low, especially in African countries. In the 
next chapter, the research design and methodology will be discussed. 
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CHAPTER 3 
 
RESEARCH DESIGN AND METHODOLOGY 
 
3.1 INTRODUCTION 
 
The previous chapter presented a literature review on the epidemiology of HBV, its 
prevention and control, as well as knowledge, attitudes and vaccination status of nurses 
regarding the prevention and control of HBV infection. This chapter will give a detailed 
outline on the research design and methodology used in this study to determine the 
knowledge, attitudes and vaccination status of registered nurses at Nyangabgwe 
Hospital regarding the prevention and control of HBV infection. 
 
3.2 STUDY DESIGN 
 
A study design is a structured approach followed by researchers to answer a particular 
research question (Joubert & Ehrlich 2014:77). In quantitative studies, there are two 
main categories of study designs, namely observational and experimental studies. In 
observational studies the researcher measures (observes) the occurrence of exposure 
and outcome, but does not intervene, whereas, in experimental studies, there is an 
active attempt to change the exposure (risk factors) of an outcome or the progress of 
the outcome. Observational studies can either be descriptive or analytical. A descriptive 
study is limited to the description of the occurrence of an outcome, and an analytical 
study goes further to identify the risk factors for the outcome by examining associations 
between the risk factors and the outcome (Joubert & Ehrlich 2014:78) 
 
The two types of descriptive studies are the cohort and the cross-sectional. Analytical 
studies are cohort, case-control, cross-sectional and ecological studies. Cross-sectional 
studies measure the prevalence of an outcome. In a cross-sectional study, the 
measurements of the risk factors (exposure) and outcome are made at the same time. 
In this study, an analytical, cross-sectional study using self-administered questionnaires 
with closed-ended questions was used. 
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3.3 STUDY SETTING 
 
Nyangabgwe Hospital is a government health institution located in Francistown, the 
second largest city of Botswana. It is the only referral hospital serving the northern 
population of the country.  
 
3.4 STUDY POPULATION 
 
A study population refers to a group from which information is gathered and conclusions 
are drawn (Joubert & Ehrlich 2014:94). In this study, the study population was defined 
as all registered nurses working at Nyangabgwe Hospital. The hospital has 
approximately 450 registered nurses. 
 
3.5 STUDY SAMPLE AND SAMPLING METHOD 
 
A study sample refers to a subset of the study population comprising those selected to 
participate in the study (Polit & Beck 2008:742). The sample size was calculated using 
the simple formula for descriptive studies: sample size, n = (z2pq)/d2. Based on previous 
studies, the following assumption was made; between 72% and 81% of the registered 
nurses should be vaccinated against HBV. Using a 95% confidence interval and an 
anticipated population proportion of 76.5%, the calculated sample size was 277, 
however, 300 was made the final sample size. Stratified random sampling was the 
sampling method used to recruit respondents. Recruitment continued until the required 
sample size within each stratum was attained. 
 
Stratified random sampling is a probability sampling technique where the study 
population is divided into different strata (subgroups) which should be mutually 
exclusive and collectively exhausted from which individuals are then selected using 
simple random sampling (Joubert & Ehrlich 2014:97-98). A stratified random sampling 
technique was chosen because it ensures proportional representation of registered 
nurses in the final sample. Each ward in the hospital where the registered nurses are 
working fall into one of the following categories (clinical area of practice): theatre, 
maternity, outpatient, intensive care, medicine, surgery, emergency and psychiatry. The 
study population was divided into different strata according to the clinical area of 
practice.  
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A sampling frame was compiled using different lists of registered nurses working in the 
respective hospital wards/departments, and using this sampling frame, the sample was 
proportionately divided into these different strata (Table 3.1). All the registered nurses 
within each stratum were assigned consecutive numbers starting from 1 to the last one. 
Random numbers were generated using Microsoft Excel. From each stratum, a simple 
random sample of respondents was then selected. The selected respondents 
(registered nurses) who agreed to participate in the study were given questionnaires. 
 
Inclusion criteria – All registered nurses whose duties directly or indirectly expose them 
to HBV in Nyangabgwe Hospital. 
 
Exclusion criteria – Registered nurses whose duties do not expose them to HBV.  
 
Table 3.1 Distribution of strata within the sample population 
 
Clinical area of practice Population Percentage Sample size 
Maternity 95 23.87 72 
Theatre 22 5.53 17 
Medicine 103 25.88 78 
Surgery 64 16.08 48 
Intensive care 43 10.80 32 
Emergency 19 4.77 14 
Outpatient 32 8.04 24 
Psychiatry 20 5.03 15 
Total 398 100.0 300 
 
 
3.6 DATA COLLECTION TOOL 
 
Data was collected using a self-administered questionnaire with closed-ended questions 
(Annexure E). A questionnaire is a list of questions which are answered by the 
respondents, and which give indirect measures of the variables under investigation 
(Joubert & Ehrlich 2014:107). The questionnaire was divided into five sections: 
demographics, knowledge, attitude, HB vaccination status and exposure. 
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3.6.1 Validity and reliability 
 
For validity, the questionnaire content was assessed by an experienced researcher. 
Thereafter, pre-testing of the questionnaire was conducted on a small sample of 10 
randomly selected registered nurses who did not meet the inclusion criteria. To these 
nurses, the objectives of the exercise were explained, and these were to check the 
clarity of the questions and observe how the respondents completed the questionnaire 
so that necessary adjustments can be done.  
 
To ensure reliability, data was collected twice from this small sample to give two sets of 
data which were coded and captured onto Statistical Package for Social Sciences 
(SPSS) software version 22 by an experienced statistician. Each set of data was 
analysed and compared for any differences. The findings were identical. 
 
3.6.2 Data collection method 
 
Permission to inform the registered nurses about the study was sought from the sisters 
in charge of the respective wards. The nurses were informed about the study at their 
workstations by the researcher. The researcher explained the structure of the 
questionnaire and mentioned the approximate time one can take to complete it. Those 
who consented to participate in the study signed a separate consent form (Annexure F) 
and were given the questionnaires to complete. Some of the respondents quickly filled 
the questionnaires and returned them to the researcher immediately. Some were left to 
complete the questionnaires which were collected from them at a later time. 
 
3.7 DATA MANAGEMENT 
 
The signed consent forms and the completed questionnaires were stored in cabinets 
only accessible to the researcher. In the interest of confidentiality, no names or any 
identifying information appeared on the questionnaires. There was no temporary 
storage for completed questionnaires at the nurses’ workstation. Whenever there were 
completed questionnaires, the researcher would be notified to come and collect them. 
No information provided by the respondents was shared with anyone. 
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Data from the questionnaires was captured onto SPSS. Coding was done on each 
questionnaire and the coded data was then captured onto SPSS. Data coding and entry 
onto SPSS continued until all the questionnaires were collected from the respondents. 
 
3.8 DATA ANALYSIS 
 
Knowledge was determined on how the respondents answered 11 questions. A score of 
1 was awarded for each correct answer and 0 for each incorrect answer or unanswered 
question. Therefore, the total knowledge score for each respondent could range from 0 
to 11. This range was divided into 3 grades: poor, moderate and good knowledge. A 
total score of 0 - 3 was poor knowledge, 4 – 7 moderate knowledge and 8 – 11 good 
knowledge. 
 
The respondents’ attitudes were based on their responses to 9 statements. The 
responses to the statements were structured on a 3-point Likert scale. For positive 
statements, an attitude score of +1 was awarded for agreeing and -1 for disagreeing. 
For negative statements, disagreeing scored +1 and agreeing scored -1. A neutral 
response scored 0 for both statements. Therefore, the total attitude scores could range 
from -9 to +9. Similarly to knowledge scores, this range was divided into 3 grades: 
negative, neutral and positive attitude. A total score of -3 and below was negative 
attitude, -2 to +3 was neutral and +4 to +9 was positive attitude. 
 
Descriptive statistics were used to summarise the data. To identify predictors of 
vaccination uptake, binomial logistic regression was used. A binomial logistic regression 
attempts to predict the probability that an observation falls into one of two categories of 
a dichotomous dependent variable based on one or more independent variables that 
can be either continuous or categorical. The dependent variable was vaccination status 
and the independent variables were knowledge, attitudes, clinical area of practice and 
demographics. The data met the following assumptions of this statistical test; the 
dependent variable is measured on a dichotomous scale, there should be one or more 
independent variables, which can be either continuous or categorical, there should be 
independence of observations and the dependent variable should have mutually 
exclusive and exhaustive categories, and data must not show multi-collinearity. 
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Chi-square test was used to determine associations among the variables, and the 
independent-samples (student’s) t-test was used to determine if there were differences 
between the mean knowledge, and mean attitude scores for the vaccinated and 
unvaccinated respondents. Statistical significance was considered when the odds ratio 
was not equal to 1, the 95% confidence interval for the odds ratio did not contain 1 and 
the p-value was less than 0.05. The data met the following assumptions for Chi-square; 
variables should be measured at an ordinal or nominal level (i.e. categorical data) and 
should consist of two or more categorical, independent groups. 
 
3.9 BIAS 
 
3.9.1 Volunteer bias 
 
The study might have been affected by volunteer bias. Responses may have been 
higher in respondents with good knowledge and attitudes as compared to respondents 
with poor knowledge and attitudes. However, non-response from those with poor 
knowledge and attitudes was minimised by making the questionnaire anonymous.  
 
3.9.2 Recall bias 
 
Recall bias was also likely source of error in this study. To complete some section(s) of 
the questionnaire, respondents had to recall past exposures to HBV. Those 
respondents previously exposed to HBV could have remembered more information 
about HBV than those never exposed. 
 
However, errors introduced by bias were minimised by stratified random sampling and 
making the study sample statistically powerful at 95% confidence interval. 
 
3.10 ETHICAL CONSIDERATIONS 
 
Ethical clearance to conduct this study was granted by the Research Ethics Committee 
of UNISA Department of Health Studies (Annexure A). Permission was requested 
(Annexure B) and granted by Health Research and Development Committee of 
Botswana Ministry of Health and Wellness (Annexure C) and the Research and Ethics 
Committee of Nyangabgwe Hospital (Annexure D). 
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To protect the respondents’ rights to self-determination and full disclosure, a consent 
form briefly explaining the purpose of the study was made available. The respondents 
were given time to go through the consent form. The researcher further explained the 
purpose of the study. The researcher emphasised that participation is entirely voluntary 
and they have the right to withdraw from participation without any consequences. Those 
who needed further clarification had their questions responded to by the researcher. 
 
Consent to participation was shown by signing the consent form. The consent forms 
and the questionnaires were separated making it impossible to link the two. The 
respondents’ right to privacy was protected by ensuring the confidentiality of the 
collected data. Anonymous questionnaires were distributed to the respondents. No 
respondent’s identification information was captured by the questionnaire.  
 
The researcher highlighted the potential risk of discomfort to the respondents, however, 
they were assured that their right to freedom from harm will be protected by ensuring 
confidentiality. The anticipated discomfort would emanate from information regarded as 
lack of knowledge and poor attitudes. The right to fair treatment was also protected as 
the benefits of the study to both the respondents and the society at large were clearly 
outlined. 
 
3.11 SUMMARY 
 
A total of 219 questionnaires were returned from the initial 300 questionnaires that were 
distributed to the registered nurses. All the 219 questionnaires had usable responses 
that constituted the data that was analysed. In the next chapter, Chapter 4, the findings 
from the data analysis will be presented. 
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CHAPTER 4 
 
PRESENTATION OF RESULTS 
 
4.1 INTRODUCTION 
 
The previous chapter outlined the research design and methodology highlighting the 
study setting, population and sampling, as well as how the data was collected and 
analysed. Ethical considerations were also discussed. This chapter will present the 
findings of the study and show how the objectives were achieved to give answers to the 
research questions.  
 
4.2 RESPONSE RATE 
 
From the 300 questionnaires that were distributed, a total of 219 questionnaires were 
returned by the respondents, resulting in a response rate of 73% (219/300).  
 
4.3 DESCRIPTIVE STATISTICS 
 
The findings of the study are presented using descriptive statistics as follows: 
 
4.3.1 Demographic profile 
 
The final study sample comprised 219 respondents. The majority of the respondents 
were females (70.3% [154/219]), had been employed as registered nurses for more 
than 9 years (72.6% [159/219]) and had a Diploma as the highest level of education 
(71.2% [156/219]) (Table 4.1, Figure 4.1 and Table 4.3). The largest number of 
registered nurses (47.9% [105/219]) were aged between 31 and 40 years old (Table 
4.2). 
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Table 4.1 Distribution of duration employed as a registered nurse 
Duration employed as a registered nurse (years) Frequency % 
≤5  15 6.8 
5-9  45 20.5 
10-14  70 32.0 
15-19  37 16.9 
>20 52 23.7 
Total 219 100 
 
 
Figure 4.1  Distribution of gender of the registered nurses 
 
Table 4.2 Age distribution of the registered nurses 
Age (years) Frequency % 
20–30  31 14.2 
31–40 105 47.9 
41–50 66 30.1 
>50  17 7.8 
Total 219 100 
 
Table 4.3 Distribution of highest level of education 
Qualification Frequency Percent 
Diploma 156 71.2 
Degree 60 27.4 
Master’s 3 1.4 
Total 219 100 
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4.3.2 Knowledge regarding prevention and control of HBV 
 
The knowledge scores could range from 0 - 11, and indeed, the actual scores of the 
respondents ranged from 0 - 11 with a mean of 7.59 (SD=1.87), a median of 8 and a 
mode of 7. The majority of the respondents (53% [116/219]) had good knowledge, 
42.5% (93/219) had moderate knowledge and 4.6% (10/219) had poor knowledge. 
 
Table 4.4 Distribution of knowledge of registered nurses 
Knowledge Frequency Percent 
Poor 10 4.6 
Moderate  93 42.5 
Good  116 53.0 
Total 219 100 
 
Table 4.5 Distribution of knowledge in clinical areas of practice 
Clinical area of practice Poor 
n (%) 
Moderate n 
(%) 
Good 
n (%) 
Total 
n (%) 
Maternity 5 (8.2) 26 (42.6) 30 (49.2) 61 (100) 
Theatre 0 (0.0) 3 (20.0) 12 (80.0) 15 (100) 
Medicine 2 (5.6) 15 (41.7) 19 (52.8) 36 (100) 
Surgery 0 (0.0) 20 (57.1) 15 (42.9) 35 (100) 
Intensive care 2 (7.1) 9 (32.1) 17 (60.7) 28 (100) 
Emergency 0 (0.0) 1 (9.1) 10 (90.9) 11 (100) 
Outpatient 0 (0.0) 14 (66.7) 7 (33.3) 21 (100) 
Psychiatry 1 (10.0) 4 (40.0) 5 (50.0) 10 (100) 
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Table 4.6 Distribution of responses to knowledge questions 
Knowledge questions 
Correct  
n (%) 
Wrong 
n (%) 
HCWs who are carriers of HBV can transmit the infection to 
patients. 
199 (90.1) 20 (9.1) 
An infected person can be asymptomatic for a long time. 179 (81.7) 40 (18.3) 
HBV infection can be prevented by a safe and effective vaccine 206 (94.1) 13 (5.9) 
One or two doses can give lifelong immunity to 90% of adults. 99 (45.2) 120 (54.8) 
After HB vaccination, there is no need for a blood test to confirm 
immunity. 
121 (55.3) 98 (44.7) 
HBV can be spread through contact with open wounds 191 (87.2) 28 (12.8) 
HBV is more infectious than HIV 164 (74.9) 55 (25.1) 
HBV can be found in the saliva of an infected person. 
118 (53.9) 101 (46.1) 
HB immunoglobulin can reduce the chances of infection after 
exposure to HBV. 
153 (69.9) 66 (30.1) 
A vaccinated person should not be considered as a possible 
source of infection 
131 (59.8) 88 (40.2) 
Some individuals will not produce antibodies to HBV after 
complete vaccination. 
101 (46.1) 118 (53.9) 
 
4.3.3 Attitudes towards the prevention and control of HBV 
 
The actual attitude scores of the respondents ranged from +2 to +9 with a mean of 7.36 
(SD=1.61), a median of 7 and a mode of 9. The majority of the respondents (96.3% 
[211/219]) had positive attitudes and 3.7% (8/219) had neutral attitudes. None of the 
respondents had negative attitudes. 
 
Table 4.7 Distribution of attitudes of registered nurses 
Attitudes Frequency Percent 
Negative  0 0 
Neutral  8 3.7 
Positive 211 96.3 
Total 219 100 
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Table 4.8 Distribution of responses to attitude questions 
 
4.3.4 Vaccination status of registered nurses 
 
Majority of the registered nurses (86.8% [190/219]) had received at least 1 dose of the 
HB vaccination series (Figure 4.2) and were regarded as vaccinated. 
 
 
Figure 4.2  Distribution of vaccination status of the registered nurses 
 
Attitude questions 
Agree 
n (%) 
Not sure 
n (%) 
Disagree 
n (%) 
HB vaccine should be given to HCWs as part of 
workplace safety. 
216 (98.6) 0 (0) 3 (1.4) 
I can agree to be tested for HBV infection. 214 (97.7) 0 (0) 5 (2.3) 
Hepatitis B screening should be made compulsory. 182 (83.1) 19 (8.7) 18 (8.2) 
My profession puts me at risk of HBV infection. 217 (98.6) 2 (0.9) 0 (0) 
Biohazard waste should be segregated properly. 216 (98.6) 0 (0) 3 (1.4) 
I always take health care standard precautions, 
therefore I am not at risk of HBV infection. 
41 (18.7) 38 (17.4) 140 (63.9) 
Due to the pressure of work, there is no time to go for 
vaccinations. 
50 (22.8) 14 (6.4) 155 (70.8) 
I can encourage a workmate to get vaccinated. 218 (99.5) 1 (0.5) 0 (0) 
In emergency situations, I would rather attend to the 
patient first than delay looking for protective clothing 
like gloves. 
24 (11.0) 2 (0.9) 193 (88.1) 
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Table 4.9 Cross tabulation between the vaccinated and clinical area of practice 
 
Table 4.10 Cross tabulation between attitude and being vaccinated 
 
Table 4.11 Cross tabulation between knowledge and being vaccinated 
 
Clinical area of practice 
Vaccinated 
No/Can’t remember 
n (%) 
Yes 
n (%) 
Maternity 11 (18.0) 50 (82.0) 
Theatre 3 (17.6) 14 (82.4) 
Medicine 4 (11.1) 32 (88.9) 
Surgery 4 (11.4) 3 1(88.6) 
Intensive care 2 (7.1) 26 (92.9) 
Emergency 3 (27.3) 8 (72.7) 
Outpatient 0 (0) 21 (100) 
Psychiatry 2 (20) 8 (80) 
Total 29 (13.2) 190 (86.8) 
Attitude 
Vaccinated 
No/Can’t remember 
n (%) 
Yes 
n (%) 
Negative 0 (0) 0 (0) 
Neutral  0 (0) 8 (100) 
Positive 29 (13.7) 182 (86.3) 
Total  29 (13.2) 190 (86.8) 
Knowledge 
Vaccinated 
No/Can’t remember 
n (%) 
Yes 
n (%) 
Poor  2 (20.0) 8 (80.0) 
Moderate   13 (14.0) 80 (86.0) 
Good  14 (12.1) 102 (87.9) 
Total  29 (13.2) 190 (86.8) 
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Figure 4.3  Number of doses received by the registered nurses 
 
Some of the vaccinated registered nurses were tested to determine if they produced the 
requisite levels of antibodies for protection against HBV. Table 4.12 shows the results 
for the antibody test among the registered nurses who received 3 doses for complete 
HB vaccination. 
 
Table 4.12 Distribution of answers to antibody test and protection 
Question 
No/Can’t remember 
n (%) 
Yes 
n (%) 
Were you tested to establish if you have antibodies 
to hepatitis B (n=104)? 
100 (96.2) 4 (3.8) 
Are you protected against HBV infection  
(n=4)? 
0 (0) 4 (100) 
 
4.3.5 Occupational exposures 
 
The majority of registered nurses have either experienced a needlestick and sharps 
injury (51.6% [113/219]) or body fluid splash (56.6% [124/219]) as an occupational 
exposure at least once in their years of practice. 
 
  
33 
Table 4.13 Distribution of answers to post-exposure management 
Exposure Question 
No/Can’t remember 
n (%) 
Yes 
n (%) 
Needle-stick or 
sharps injury 
Did you report the incident 
(n=113) 
25 (22.1) 88 (77.9) 
Did you receive PEP for HBV 
(n=88)  
55 (62.5) 33 (37.5) 
Blood or body 
fluid splash 
Did you report the incident 
(n=124) 
46 (37.1) 78 (62.9) 
Did you receive PEP for HBV 
(n=78) 
100 (80.6) 24 (19.4) 
 
Among the exposed, only 37.5% (33/113) of those who had a needlestick and sharps 
injury, and 19.4% (24/124) of those who experienced body fluid splash received post-
exposure prophylaxis against HBV.  
 
4.3.6 Associations between knowledge, attitudes and vaccination status 
 
The independent variables, knowledge and attitudes were collapsed into dichotomous 
variables. Odds ratios were computed to determine and measure any associations 
between the independent variables and the dependent variable (vaccination status). 
Statistical significance of any association found was determined by the p-values of Chi-
square and Fisher’s exact tests. Fisher’s exact p-value was used as the obtained 
dichotomous data for attitude did not meet the assumption that all cells should have 
expected counts greater than five. No statistically significant association was found 
(Table 4.14 and Table 4.15). 
 
Table 4.14 Association between knowledge and vaccination status 
 
Knowledge 
Vaccinated 
Odds ratio 
Chi-square p-
value 
No/Can’t remember 
n (%) 
Yes 
n (%) 
Moderate-poor 15 (51.7) 88 (46.3) 
0.805 0.587 Good 14 (48.3) 102 (53.7) 
Total 29 (100) 190 (100) 
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Table 4.15 Association between attitudes and vaccination status 
 
4.3.7 Factors predicting vaccination status 
 
Binomial logistic regression was used to identify significant factors influencing 
vaccination uptake by the registered nurses. A positive attitude score was a significant 
factor influencing vaccination uptake (OR=1.424, p=0.003). Table 4.16 shows that 
respondents were 1.424 times more likely to vaccinate as their attitude score increased 
by 1. Among the demographic variables, gender was the only significant factor 
influencing vaccination uptake. The odds of being vaccinated was 3.479 times greater 
for females as opposed to males (Table 4.16). Chi-square test of independence was 
also conducted between demographic variables and vaccination status, and gender was 
the only variable significantly associated with vaccination status (Table 4.17). 
 
Table 4.16 Binomial logistic regression 
 
Table 4.17 Cross tabulation between gender and vaccination status 
 
The Independent samples (Student’s) t-test (Table 4.18) was used to determine if there 
was a difference between the mean knowledge and attitude scores for the registered 
nurses who were vaccinated against those not vaccinated. For knowledge scores there 
Attitude 
Vaccinated 
Odds ratio 
Fisher’s 
exact p-value 
No/Can’t remember 
n (%) 
Yes 
n (%) 
Neutral-negative 0 (0) 8 (4.2) 
Undefined 0.601 Positive 29 (100) 182 (95.8) 
Total  29 (100) 190 (100) 
Variables P-value Odds ratio 
(OR) 
95% CI for OR 
Lower Upper 
Knowledge scores 0.253 1.136 0.913 1.414 
Attitude scores 0.003 1.424 1.127 1.800 
Gender  0.004 3.479 1.495 8.098 
Gender 
Vaccinated Chi 
square 
P- value 
Odds 
ratio 
(OR) 
95% CI for OR 
No/Can’t remember  
n (%) 
Yes  
n (%) 
Lower Upper 
Male 15 (51.7) 50 (26.3) 
0.005 3.000 1.352 6.655 Female  14 (48.3) 140 (73.7) 
Total 29 (100) 190 (100) 
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was no significant difference (p=0.239). Nonetheless, the mean attitude score was 
significantly different (p=0.001). 
 
Table 4.18 Comparison of knowledge and attitude scores 
 
4.4 DISCUSSION AND INTERPRETATION OF RESULTS 
 
Among any group of HCWs, one would anticipate a high level of knowledge regarding 
prevention and control of diseases. However, knowledge gaps still exist, especially 
among highly trained medical professionals. In this study, almost half of the registered 
nurses (47.1% [103/219]) had poor to moderate knowledge. On the other hand, none of 
the registered nurses had negative attitudes. As a matter of fact, the registered nurses 
had commendable positive attitudes especially regarding HB vaccination. This positive 
attitude significantly predicted the uptake of HB vaccination by the registered nurses. 
Despite commendable positive attitude in the majority, complete vaccination coverage 
was not satisfactory. Positive attitudes without the positive move will not preclude HBV 
entry into the HCWs. More females were vaccinated as compared to males, and gender 
was the only demographical variable significantly associated with HB vaccination status.  
 
4.5 SUMMARY 
 
This chapter has presented the results of the study using tables, pie charts and graphs 
to summarise the data in numbers and percentages. The next chapter will give a more 
detailed discussion of the study findings presented in this chapter. 
 
 
Variables Mean score Mean 
difference 
P-
value 
95% CI for OR 
Vaccinated Unvaccinated Lower Upper 
Knowledge 7.65 7.21 -0.440 0.239 -1.176 0.295 
Attitude 7.50 6.45 -1.052 0.001 -1.669 -0.435 
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CHAPTER 5 
 
DISCUSSION, CONCLUSIONS, LIMITATIONS AND 
RECOMMENDATIONS 
 
5.1 INTRODUCTION 
 
This chapter will give a detailed discussion of the findings of this study presented in 
Chapter 4. The findings addressed the research questions, and this discussion will 
generate conclusions and recommendations drawn from the interpretation of the 
findings.  
 
5.2 RESPONSE RATE 
 
Response rates are calculated by dividing the number of usable responses returned by 
the total number eligible in the sample chosen (Fincham 2008). An overall response 
rate of 73% was obtained in this study and this was acceptable as response rates 
approximating 60% for most researches should be the goal of researchers (Fincham 
2008). 
 
5.3 KNOWLEDGE 
 
The majority of the registered nurses (53.0%) had good knowledge. A similar study 
conducted in Dhaka city Bangladesh on 300 nurses found that 67.3% of the 
respondents had adequate knowledge regarding HBV prevention (Mehriban, Ahsan & 
Islam 2014:50). 
 
5.3.1 Knowledge about the vaccine 
 
In this study, a vast majority of the registered nurses, 94.1% (206/219) knew about the 
availability of an effective and safe HBV vaccine. A similar finding was obtained in a 
study conducted in India (Amanpreet et al 2016:258). Results of this study showed that 
69.9% of the respondents were aware that HB immunoglobulin reduces the possibility of 
infection after HBV exposure and this was in line with the findings of a study in Ethiopia 
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(Abeje & Azage 2015). Of the respondents in this study, 55.3% (121/219) knew that 
there is need to confirm immunity after complete vaccination, similar findings were 
obtained in two studies; one conducted in South Africa (Burnett, Francois, Mphahlele, 
Mureithi, Africa, Satekgea, Mokonoto, Meheus & Sprundel 2011:4295) and the other in 
Cameroon (Tatsilong et al 2016) among HCWs. However, the majority of the 
respondents, 53.9% (118/219) and 54.8% (120/219) did not know that after complete 
vaccination some individuals may not produce antibodies to HBV and that one or two 
doses (incomplete vaccination) do not give lifelong immunity to 90% of adults, 
respectively. These were unanticipated knowledge gaps taking into account their 
college training curriculum. 
 
5.3.2 Knowledge about HBV transmission 
 
In this study, 59.8% (131/219) knew that a vaccinated person should be considered as 
a possible source of HBV infection. This is similar to the findings of the study conducted 
in South Africa among HCWs where 50.9% of the respondents knew the same (Burnett 
et al 2011:4295). About three-quarters of the registered nurses were aware that HBV is 
more infectious than HIV. Similarly, in South Western Nigeria, the majority of the HCWs  
(87.1%) were of the opinion that hepatitis B virus is about 100 times more infectious 
than HIV (Akpor & Akingbehin 2017). 46.1% of the registered nurses did not know that 
HBV can be found in the saliva of an infected person. A study conducted among nurses 
in Dhaka, Bangladesh revealed a comparable finding where more than half (52.9%) 
stated that it cannot be transmitted through saliva (Khan, Riya, Islam & Majeed 
2017:38). The majority (90.1% [199/219]) knew that an infected HCW can transmit HBV 
to patients. Similarly, this was found in a study conducted in Kuwait where the HCWs 
knew the same (Habiba, Ghadeer, Alrashidi, Al-otaibi, Almutairi, Makboul & El-Shazly 
2012:78).  
 
5.4 ATTITUDES 
 
The majority of the registered nurses 96.3% (211/219) had positive attitudes. A similar 
finding was discovered in the Gaborone study, where 97.4% (114/117) of the 
respondents had positive attitudes (Machiya et al 2015:256).  
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5.4.1 Attitudes towards HB vaccination 
 
Majority of the registered nurses 98.6% in this study agreed that HBV vaccine should be 
given to HCWs as part of workplace safety, this was consistent with the findings of a 
study conducted in Ethiopia where 91.7% had a similar opinion (Abeje & Azage 2015). 
Only 1.4% (3/219) of the registered nurses in this study disagreed. Almost all the 
registered nurses (99.5% [218/219]) in this study agreed they can encourage a 
workmate to get vaccinated. A similar finding was reported in a study conducted in 
Cameroon study where 93% felt that the vaccine should be compulsory and all (100%) 
were willing to recommend it to others (Tatsilong et al 2016). In this study, a majority of 
the registered nurses (70.8% [155/219]) disagreed to the statement “Due to pressure of 
work, there is no time to go for vaccinations” indicating that vaccination uptake can 
never be deterred by their busy schedules as cited by HCWs in other studies as 
reasons for non-compliance to vaccination.  
 
5.4.2 Attitude towards risk of occupational exposure 
 
The majority (63.9% [140/219]) of the registered nurses disagreed to the statement “I 
always take health care standard precautions, therefore I am not at risk of HBV 
infection”. Similarly, 79.5% (128/161) of HCWs disagreed to the same statement in a 
study done in South Africa (Burnett et al 2011:4295). This shows that the registered 
nurses acknowledge the fact that standard precautions can reduce but do not eliminate 
the risk of HBV infection. 98.6% (217/219) of the respondents in this study concurred 
that their work exposes them to HBV infection, and this is consistent to the findings of 
the study conducted in India (Amanpreet et al 2016:258).  
 
In this study, 83.1% (182/219) of the registered nurses agreed that HBV screening 
should be made compulsory. In addition, 97.7% (217/219) indicated they can agree to 
be tested for HBV. This shows they fully acknowledge the magnitude of HBV infection 
as an occupational hazard, and that a HCW, if infected, is at risk of transmitting HBV to 
patients even though published cases of HBV transmission from HCW to the patient are 
relatively rare (Lewis et al 2015:488). A study in Tanzania revealed an overall 
prevalence of chronic HBV infection (HBsAg positivity) among HCWs of 7.0%, and that 
36.5% of HCWs achieved immunity due to healed infection with HBV (Mueller et al 
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2015). This further emphasises that HCWs have a high risk of becoming infected with 
HBV through their occupation. 
 
5.5 VACCINATION STATUS  
 
Majority of the registered nurses (86.8% [190/219]) had received at least one dose of 
the HB vaccination series. This finding is much better compared to that of the study 
conducted in Gaborone where only 50.9% (59/116) of the HCWs had received at least 
one dose (Machiya et al 2015:256). Among the vaccinated registered nurses in this 
study, 54.7% (104/190) had received all the 3 doses for complete vaccination, in a 
similar fashion, 61% (36/59) of the HCWs in the Gaborone study had received the 
complete 3 dose series (Machiya et al 2015:256). On the contrary, one Ethiopian study 
had only 10% of the respondents who reported that they had received one or more 
doses of the hepatitis B vaccine (Abeje & Azage 2015).  
  
It is imperative that all HCWs should have serologic testing 1-2 months following the 
final dose of the hepatitis B vaccine series (Health Protection Surveillance Centre 
2016). An anti-HBs serologic test result of >10mIU/ml indicates immunity, otherwise, the 
HCW is susceptible to HBV infection. Only 4.2% (8/190) of those vaccinated in this 
study had their immunity checked and 50% (4/8) of those (whose immunity was 
checked) were protected against HBV. This is in contrast to the study done in South 
Africa where it was found that 27.6% (32/116) had their immunity checked and 93.75% 
(30/32) stated they were protected (Burnett et al 2011:4296). In this study, only 2.1% 
(4/190) of the vaccinated registered nurses were confirmed to be protected. This 
suggests that 97.9% (186/190) of the registered nurses may still be susceptible to HBV 
infection. The study in Tanzania also revealed that immunity (anti-HBs positivity) was 
present in 56.9 % of the HCWs but 31.3 % of them were still susceptible to HBV 
infection as shown by anti-HBs levels below 10mIU/ml (Mueller et al 2015). 
 
The majority of the registered nurses had experienced either a needle-stick injury 
(51.6% [113/219]) or body fluid splash (56.6% [124/219]) as exposure at least once 
during their career. This finding is comparable to an Iranian study where 57% of nurses 
reported a history of NSI (Farahnaz, Fiborz, Mohammad & Tolou 2017:36). In this study, 
the majority (77.9% [88/113]) of the registered nurses exposed through a needle-stick or 
sharps injury reported the incident, but surprisingly, only 37.5% (33/88) of those who 
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reported received PEP for HBV. Considering that only 2.1% of the registered nurses 
were protected against HBV, a higher proportion, if not all, of those who reported 
exposure incidents should have received PEP. Similarly, in another South African study, 
a small proportion (8.7%) of medical practitioners received prophylactic hepatitis B 
immunoglobulin after exposure (De Villiers et al 2007:14). Importance of vaccination is 
demonstrated in this South African study as two exposed medical practitioners 
seroconverted to HBV positivity, and in both cases, neither was vaccinated against HBV 
infection prior to exposure (De Villiers et al 2007:14).   
 
5.6 ASSOCIATION 
 
No statistically significant associations were observed between knowledge, attitudes 
and vaccination status. These associations were tested using the Chi-square test of 
association. Among the demographical variables, gender was the only variable 
significantly associated with vaccination status (p=0.005). 
 
5.7 PREDICTORS OF VACCINE UPTAKE 
 
Positive attitude and being a female were predictors of HB vaccination uptake by the 
registered nurses in this study. Majority of the respondents had a positive attitude and 
the findings showed that a positive attitude significantly predicted HB vaccination 
uptake. This was compatible with the findings of the South African study in which a 
positive attitude significantly predicted HB vaccine uptake among HCWs (Burnett et al 
2011:4296).  
 
In this study, the level of knowledge was not a predictor of vaccine uptake. This is in 
contrast to the findings of an Ethiopian study conducted amongst nurses where the level 
of knowledge towards hepatitis B vaccination was one of the most important predictors 
of vaccination status (Yimer et al 2017). 
 
In this study, gender was a significant predictor of vaccination uptake. The likelihood of 
being vaccinated was 3.479 times greater in female registered nurses than male 
registered nurses. A study conducted among high-risk public safety workers in Nigeria 
revealed a comparable finding where women were associated with about twice the 
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likelihood of having received full dose HB vaccination as compared to men (Ochu & 
Beynon 2017).  
 
5.8 CONCLUSION 
 
Despite the majority having good knowledge, registered nurses showed a lack of 
requisite knowledge regarding HB prevention and control. Knowledge gives the power 
to judge situations and make decisions voluntarily. Knowledge gaps were identified in 
HB vaccine efficacy and transmission routes like saliva. Complete HB vaccination 
uptake is one of the best decisions a registered nurse should ever make during his/her 
practice. Not all registered nurses received the 3 dose series for complete vaccination, 
and only a few of those fully vaccinated were protected against HBV infection. It is 
possible that a significant number of registered nurses at Nyangabgwe Hospital may still 
be susceptible to HBV infection. There is an urgent need to safeguard the registered 
nurses and other HCWs with complete HB vaccination, especially considering that 
majority of the registered nurses reported the incidents of exposure but only a few 
received PEP. 
 
Although efforts to initiate the HB vaccination series are relatively high among the 
registered nurses, complete vaccination coverage still remains low considering the 
occupational risk they are exposed to. At Nyangabgwe hospital, the HB vaccine is given 
to all HCWs for free unlike in other studies where the cost of the hepatitis B vaccine has 
been documented as a significant barrier to the uptake of the vaccine among HCWs. 
Since positive attitude was a significant predictor of vaccine uptake, erratic availability of 
the HB vaccine at the hospital may be a possible barrier for vaccination uptake. 
  
5.9 RECOMMENDATIONS 
 
5.9.1 Recommendations for clinical practice 
 
The Botswana Ministry of Health and Wellness should develop, implement and 
strengthen occupational safety and health policies. Such policies should include a 
hepatitis B prevention and control policy that ensures a consistent supply of the HB 
vaccine to all the health facilities, and compulsory HB screening and vaccination among 
HCWs. 
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A post-vaccination test for immunity after complete vaccination should be mandatory as 
part of the HB vaccination programme. This also helps to identify non-responders to HB 
vaccination. 
 
5.9.2 Recommendations for health education 
 
The study has shown that a number of exposure incidents are not reported. 
Underreporting results in underestimates of adequate statistics that prompt the infection 
control managers to enact and review public health policies and strategies. Guidelines 
and principles of post-exposure management should be implemented and adhered to 
on all exposure incidents. The hospital infection control programmes should include 
effective educational training to improve the dissemination of HBV knowledge and 
encourage hepatitis B vaccination uptake among all HCWs.  
 
5.9.3 Recommendations for further research 
 
The study has demonstrated that complete vaccine uptake still remains low among 
HCWs. This study finding can form a strong basis for recommended future studies 
which include: a study to ascertain nurses’ perception of HB vaccination and subjective 
reasons for poor compliance of vaccine uptake; a quantitative seroprevalence study to 
determine the actual immune status of nurses (and other HCWs) at Nyangabgwe 
hospital and estimate the prevalence of HBV in this study group for appropriate 
intervention. 
 
5.10 LIMITATIONS OF THE STUDY 
 
In spite of the study being relatively cheap and easy to conduct, there is a possibility of 
recall bias on the self-reported vaccination status, the number of HB vaccine doses 
received, exposure incidents and post-vaccination testing for immunity. Those 
respondents previously exposed to HBV could have remembered more information 
about HBV than those never exposed. The study might have also been affected by 
volunteer bias; responses may have been higher in respondents with good knowledge 
and positive attitudes compared to those with poor knowledge yet positive attitudes. The 
study might have suffered sampling bias, especially where it was difficult to locate some 
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registered nurses who were randomly selected to participate due to annual, sick and 
study leaves, and outreach programmes of the hospital. 
 
5.11 CONCLUDING REMARKS 
 
Hepatitis B can be prevented, diagnosed, treated and even cured. While testing and 
treatment are key to eliminating hepatitis, a strong focus on prevention is required to 
achieve the goal to eliminate hepatitis by 2030 (WHO 2018). The study has shown that 
registered nurses and other HCWs are aware of the preventive practices regarding 
control of hepatitis B, but as long as they are not completely vaccinated and tested to 
ensure they have achieved a protective level of antibodies against HBV, they still 
remain at risk of HBV infection. It is the responsibility of every HCW to adequately 
conform to all the preventive measures to ensure the least possible risk of contracting 
the infection from HBV and other blood-borne viruses.  
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ANNEXURE B 
Permission requested to do the study 
23 February 2018 
 
Nyangabgwe Hospital Laboratory 
Private Bag 127 
Francistown 
 
The Chairperson 
Research Ethics Committee 
Nyangabgwe Hospital 
P. Bag 127 
Francistown 
 
Dear Sir/Madam 
 
RE: APPLICATION TO CONDUCT RESEARCH 
 
This letter serves as an application to conduct a research at Nyangabgwe Hospital. I am 
a student in the School of Public Health, University of South Africa for the Master of 
Public Health programme where a research report is mandatory to fulfil the 
requirements of the programme.  
 
Find enclosed the approval for the intended research from the MoHW, the research 
proposal, the questionnaire (data collection tool) and the consent form. Should you have 
any questions concerning the study, please do not hesitate to contact the researcher on 
74185290 / 2411353 or the research supervisor, Dr TSB Mokoboto-Zwane on +2712 
4293111. 
 
I look forward to your most favourable response. 
 
Yours faithfully 
 
 
 
Leighton Taurai Kapungumberi 
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ANNEXURE C 
Approval from MOHW 
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ANNEXURE D 
Approval from the institution (Nyangabgwe Hospital) 
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ANNEXURE E 
Questionnaire (for registered nurses) 
 
Research title: Hepatitis B prevention and control: Knowledge, attitudes and vaccination 
status of registered nurses at Nyangabgwe Hospital in Francistown, Botswana.  
 
Please answer the following questions by placing a tick () in the box that corresponds 
to the answer. If you make a mistake cancel by making a straight line across the tick () 
and tick the correct answer.  For question 1, write your age. 
 
Section A  
 
1. Age (years) ________ 
 
2. Gender 
 
Male  
Female  
 
3. Highest level of education 
 
Diploma Degree Masters 
   
 
4. Clinical area of practice (workstation) 
 
 
5. Years in profession 
 
 
 
 
 
Section B  
 
6. Health care workers (HCWs) who are carriers of hepatitis B virus (HBV) can transmit 
the infection to patients. 
 
Yes No Don’t know 
   
 
Maternity Theatre Medicine Surgery Intensive 
care 
Emergency  Outpatient Psychiatry 
        
< 5 5-9 10-14 15-19 >20 
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7. An infected person can be asymptomatic for a long time  
     
Yes No Don’t know 
   
                                               
8. HBV infection can be prevented by a safe and effective vaccine. 
 
Yes No Don’t know 
   
 
9. One or two doses of HBV vaccine give lifelong immunity to 90% of adults. 
 
Yes No Don’t know 
   
 
10. After vaccination for hepatitis B, there is no need for a blood test to confirm           
immunity against hepatitis B. 
 
Yes No Don’t know 
   
 
11. HBV can be spread through contact with open wounds. 
 
Yes No Don’t know 
   
 
12. HBV is more infectious than HIV.  
 
Yes No Don’t know 
   
 
13. HBV can be found in the saliva of an infected person. 
 
Yes No Don’t know 
   
 
14. Hepatitis B immunoglobulin can reduce chances of infection after exposure to HBV. 
 
Yes No Don’t know 
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15. A person vaccinated against hepatitis B should not be considered as a possible 
source of hepatitis B. 
 
Yes No Don’t know 
   
 
16. Some individuals will not produce antibodies to HBV after complete vaccination. 
 
Yes No Don’t know 
   
 
Section C 
 
17. HBV vaccine should be given to Health Care Workers as part of workplace safety. 
 
Agree Disagree Not sure 
   
                 
18. I can agree to be tested for HBV infection. 
 
Agree Disagree Not sure 
   
 
19. Hepatitis B screening should be made compulsory. 
 
Agree Disagree Not sure 
   
 
20. My profession puts me at risk of HBV infection 
 
Agree Disagree Not sure 
   
 
21. Biohazard waste should be segregated properly.  
 
Agree Disagree Not sure 
   
 
22. I always take health care standard precautions, therefore I am not at risk of HBV 
infection. 
 
Agree Disagree Not sure 
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23. Due to the pressure of work, there is no time to go for vaccinations. 
 
Agree Disagree Not sure 
   
 
24. I can encourage a workmate to get vaccinated. 
 
Agree Disagree Not sure 
   
 
25. In emergency situations, I would rather attend to the patient first than delay looking 
for protective clothing like gloves. 
 
Agree Disagree Not sure 
   
 
Section D 
 
26. Have you ever been vaccinated against HBV infection? 
 
Yes No Can’t remember 
   
 
Please complete 27-35 only if your answer to 26 is ‘yes’ 
 
27. How many doses did you receive? 
 
1 2 3 Can’t remember 
    
 
28. Were you tested to establish if you have antibodies to hepatitis B? 
 
Yes No Can’t remember 
   
 
29. If you were tested, are you protected against HBV infection? 
 
Yes No Can’t remember 
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30. Is there a valid documentation to show that you were vaccinated? 
 
Yes No Can’t remember 
   
 
31. The vaccine caused mild side effects. 
Yes No Can’t remember 
   
 
Section E 
 
32. Have you ever had a contaminated needle stick or sharps injury? 
 
Yes No Can’t remember 
   
 
33. Have you ever experienced patient’s blood or body fluids splashing into your face? 
 
Yes No Can’t remember 
   
 
Please complete 34-35 only if your answer to 32 and/or 33 is ‘yes’ 
 
34. Did you report the incident? 
 
Yes No Can’t remember 
   
 
35. Did you receive any post-exposure prophylaxis against HBV infection? 
 
Yes No Can’t remember 
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ANNEXURE F 
Consent form 
Title of the Study  
 
Hepatitis B prevention and control: knowledge, attitudes and vaccination status of 
nurses in Botswana.  
 
Introduction 
 
Nurses contribute the largest proportion of health care workers and their general 
knowledge and attitudes regarding the prevention of communicable diseases have a 
direct impact on the goals of public health. Occupational exposures are common within 
health facilities putting both nurses and patients at risk of infections. It is therefore 
important to evaluate how well informed and protected nurses are, regarding HBV 
infection and proper patient care.  
 
Purpose of the study  
 
The objectives of the study is to determine the knowledge, attitudes and vaccination 
status of nurses regarding the prevention and control of hepatitis B at Nyangabgwe 
Hospital. The study will also determine the factors predicting the uptake of hepatitis B 
vaccination by the registered nurses. 
 
Eligibility criteria 
 
Inclusion criteria – All registered nurses whose duties directly or indirectly expose 
them to the risk of HBV infection. 
 
Exclusion criteria – All registered nurses whose duties do not expose them to the risk 
of HBV infection. 
 
Risks and/or discomfort 
 
The anticipated discomfort may be disclosure of information regarded as poor 
knowledge or poor attitudes. 
 
Benefits 
 
The study results may help improve and strengthen the Hospital infection control and 
occupational safety measures towards risk of exposure to hepatitis B.  
 
Compensation 
 
No cost will be incurred by the respondents, neither will there be compensation nor 
incentives. 
 
Voluntary participation and right to withdraw 
 
Participation is entirely voluntary, should respondents wish to withdraw from 
participation, they are free to do so and they will not be held accountable. 
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Privacy, anonymity and confidentiality 
 
Privacy and anonymity of respondents will be assured. The respondents’ right to privacy 
will be protected by ensuring the confidentiality of the collected data. Anonymous 
questionnaires will be distributed to the respondents. No respondent’s identification 
information will be captured by the questionnaire. All the collected information will be 
destroyed upon completion of the study. The results of the study will be availed to 
Nyangabgwe Hospital Research committee, Ministry of Health Botswana and the 
University of South Africa.  
 
Contact details 
 
For more information regarding the research, please feel free to contact: 
The Researcher – Mr Leighton Taurai Kapungumberi  
Tel 2411353, Mobile 74185290/ 72114091  
 
or 
 
The Research supervisor – Prof TSB Mokoboto-Zwane  
Tel +2712 4293111 
 
Statement by respondent 
 
 I have had the research satisfactorily explained to me in verbal and/or written 
form by the researcher. 
 I understand that participation in the research will involve completing a 
questionnaire that I have to fill on my own. 
 I understand that I may withdraw from this study at any time without having to 
give an explanation or face consequences. 
 I understand that all the information about me will be treated in strict 
confidence and that I will not be named in any written work arising from this 
study. 
 I understand that questionnaires will be used solely for research purposes 
and will be destroyed upon completion of the study. 
 I have seen the approval documents for this study from the relevant 
authorities of UNISA, Ministry of Health and Wellness, and Nyangabgwe 
Hospital. 
 
 
Name of respondent…………………………………………………………………. 
 
Signature…………………………………............    Date………………………….. 
 
 
 
 
..........................................................................    Date...................................... 
RESEARCHER’S SIGNATURE         
Leighton Taurai Kapungumberi 
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ANNEXURE G 
Statistician’s letter 
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ANNEXURE H 
English language editor’s letter 
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ANNEXURE I 
Turnitin originality report 
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